Since the cloning of the ATM gene in 1995 [3], many case-control studies have carried out mutation screening and single nucleotide polymorphism (SNP) genotyping to clarify the role of ATM genetic variation in breast cancer predisposition [4-10]. This evidence concerns the gene ATM and breast carcinoma.